chr8-143818494-C-T
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The NM_078480.3(PUF60):c.389G>A(p.Arg130His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R130C) has been classified as Pathogenic.
Frequency
Consequence
NM_078480.3 missense
Scores
Clinical Significance
Conservation
Publications
- 8q24.3 microdeletion syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
- syndromic intellectual disabilityInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_078480.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PUF60 | NM_078480.3 | MANE Select | c.389G>A | p.Arg130His | missense | Exon 6 of 12 | NP_510965.1 | ||
| PUF60 | NM_001362895.2 | c.500G>A | p.Arg167His | missense | Exon 7 of 13 | NP_001349824.1 | |||
| PUF60 | NM_001362896.2 | c.500G>A | p.Arg167His | missense | Exon 7 of 13 | NP_001349825.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PUF60 | ENST00000526683.6 | TSL:1 MANE Select | c.389G>A | p.Arg130His | missense | Exon 6 of 12 | ENSP00000434359.1 | ||
| PUF60 | ENST00000349157.10 | TSL:1 | c.338G>A | p.Arg113His | missense | Exon 5 of 11 | ENSP00000322036.7 | ||
| PUF60 | ENST00000453551.6 | TSL:1 | c.260G>A | p.Arg87His | missense | Exon 6 of 12 | ENSP00000402953.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1455154Hom.: 0 Cov.: 36 AF XY: 0.00 AC XY: 0AN XY: 723354
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
8q24.3 microdeletion syndrome Pathogenic:2
This variant has been previously reported as a de novo change in two patients with Verheij syndrome (VRJS, MIM: #615583) (PMID: 30160830, 29300383). It is absent from the gnomAD population database and thus is presumed to be rare. The c.389G>A (p.Arg130His) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Based on the available evidence, the c.389G>A (p.Arg130His) variant is classified as Likely Pathogenic.
CHARGE syndrome Pathogenic:1
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30160830, 29300383)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at